Company Quick10K Filing
Biondvax Pharmaceuticals
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
20-F 2018-12-31 Annual: 2018-12-31
20-F 2017-12-31 Annual: 2017-12-31
20-F 2016-12-31 Annual: 2016-12-31
20-F 2015-12-31 Annual: 2015-12-31

Biondvax Pharmaceuticals Financials

-

BVXV Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Arsanis (ASNS) 29,581 133,507 37,339 3,500 0 -22,768 -21,230 -39,343
Cidara Therapeutics (CDTX) 44,703 51,752 19,970 0 0 -56,069 -55,651 130
Xtant Medical Holdings (XTNT) 32,125 44,497 85,573 67,526 39,499 -64,228 -53,862 98,746
Ampliphi Biosciences (APHB) 2,988 34,916 12,286 0 0 -13,742 -13,208 -10,904
Protalix Biotherapeutics (PLX) 55,242 122,727 663 -1,254 -20,770 -16,381 -25,096
Organovo Holdings (ONVO) 57,323 43,451 7,312 3,070 2,608 -25,542 -24,645 21,757
Neuralstem (CUR) 311 3,522 1,559 0 0 -6,702 -6,545 -1,971
Vical (VICL) 19,415 42,701 1,159 171 0 -12,124 -12,004 8,602
Tracon Pharmaceuticals (TCON) 23,950 27,951 19,032 0 0 -30,380 -30,353 4,614
Cytrx (CYTR) 11,100 19,942 1,855 250 0 -8,329 -7,551 -8,277
Aevi Genomic Medicine (GNMX) 11,658 4,021 3,689 0 0 -22,359 -22,359 8,221
Vaxart (VXRT) 11,208 37,250 21,405 7,455 0 -18,426 -13,768 -5,092
Trovagene (TROV) 13,984 13,868 5,020 467 440 -15,958 -15,494 3,193
Titan Pharmaceuticals (TTNP) 18,683 6,761 7,332 3,832 3,060 -15,263 -14,984 20,422
Proteon Therapeutics (PRTO) 8,030 11,600 2,123 0 0 -21,615 -21,615 -2,805
Microbot Medical (MBOT) 3,317 12,575 4,594 0 0 -7,381 -7,381 -5,812
Biondvax Pharmaceuticals (BVXV) 0 105,837 0 0 0 0 -707
Cellular Biomedicine Group (CBMG) 190,535 117,687 35,510 145 78 -42,696 -38,564 133,821
Aptose Biosciences (APTO) 38,190 4,434 0 0 -17,985 -17,903 -26,898
Asterias Biotherapeutics (AST) 29,814 5,309 731 540 -20,296 -18,593 -6,524

Balance Sheet ($'000)2017-12-312018-12-31
Cash857707
Accounts Receivable
Inventory
PP&E
Assets81,695105,837
Accounts Payable
Long-Term Debt
Liabilities
Stockholders' Equity
Income Statement ($'000)2017-12-312018-12-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($'000)2017-12-312018-12-31
Cash Operating
Cash Investing
Cash Financing